Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial.
from Latest Science News -- ScienceDaily https://ift.tt/2RfNc8m
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment